Eyenovia, Inc.

Home » Eyenovia, Inc.

IPO

Eyenovia, Inc.

They are a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing their patented piezo-print technology to deliver micro-doses of active pharmaceutical ingredients, or micro-therapeutics, topically to the eye.

Symbol

EYEN

Price Range
TBD

Anticipated Shares
2,730,000

Effective Date
January 25, 2018

Underwriters
Ladenburg Thalmann, Roth Capital Partners

To view the prospectus for Eyenovia, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253